Report cover image

Veterinary Regenerative Medicine Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Publisher Global Market Insights
Published Jan 08, 2025
Length 99 Pages
SKU # GMI19636301

Description

The veterinary regenerative medicine market is poised to record 9.9% CAGR during 2024-2032, due to the increasing prevalence of chronic ailments and orthopedic issues in animals. With pet ownership rising, the demand for advanced veterinary solutions has surged. According to the American Pet Products Association, 68% of U.S. households owned a pet in 2022. Regenerative medicine, including stem cell therapy and tissue engineering, offers treatments for conditions like osteoarthritis, tendon injuries, and cardiac diseases in animals. These therapies improve pets' quality of life and extend their lifespans. Advancements in biotechnology and increased R&D investments are also driving the market growth. Collaborations between research institutions, veterinary clinics, and pharmaceutical companies are developing effective regenerative therapies. For instance, a 2023 study by the Journal of Veterinary Science highlighted a 20% improvement in osteoarthritis symptoms in dogs treated with stem cell therapy. Regulatory approvals for new treatments and growing awareness among veterinary professionals about regenerative medicine's benefits are favoring adoption. The trend towards personalized medicine and innovative delivery systems enhances treatment efficacy and accessibility, shaping the industry outlook. The overall veterinary regenerative medicine industry is classified based on animal type, product type, application, end-user, and region. The biological therapy segment is slated to record robust growth through 2032, primarily due to the efficacy and innovative nature of these treatments. Biological therapies are utilized for their regenerative capabilities and potential to treat a variety of animal conditions such as musculoskeletal injuries, wound healing, and chronic inflammatory diseases. These therapies leverage the body's natural healing processes, offering a minimally invasive and highly effective alternative to traditional treatments. The growing body of clinical evidence supporting the safety and effectiveness of biological therapies, along with rising investment in R&D, is driving their adoption in veterinary practices. The trauma/wound care application segment will register notable industry share by 2032, due to the increasing prevalence of injuries and surgical procedures among pets and livestock. Regenerative therapies, such as stem cell treatments and platelet-rich plasma (PRP), accelerate healing, reduce inflammation, and minimize scarring. These advanced therapies provide a more effective and less invasive alternative to conventional treatments, leading to improved outcomes and faster recovery times for animals. The growing awareness among veterinarians and pet owners about the benefits of regenerative medicine for trauma and wound care, coupled with ongoing advancements in treatment methodologies and product availability, is driving the expansion of this segment. Asia Pacific veterinary regenerative medicine market is poised for substantial growth through 2032. Increasing pet ownership, especially in urban areas, is contributing to a rising demand for advanced veterinary care solutions. There is growing awareness among pet owners and veterinarians about the benefits of regenerative therapies, such as stem cell treatments and tissue engineering. Additionally, significant investments in veterinary healthcare infrastructure and rising disposable incomes are enabling greater access to these innovative treatments. The region's strong focus on R&D, supported by collaborations between academic institutions and biotechnology firms, is further accelerating the introduction of novel regenerative medicine for animals across Asia Pacific.

Table of Contents

99 Pages
Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope and definitions
1.3 Research design
1.4 Market size estimates and calculations
1.4.1 Approach 2: Investor presentation
1.4.2 Approach 1: Data mining approach
1.5 Key trends for market estimates
1.6 Forecast model
1.7 Primary research & validation
1.7.1 Primary sources
1.7.2 Data mining sources
1.7.2.1 Paid sources 18
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360 degree synopsis
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Animal type trends
2.1.4 Product type trends
2.1.5 Application trends
2.1.6 End Use trends
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of chronic and degenerative conditions
3.2.1.2 Growing advancement in regenerative medicine
3.2.1.3 Increasing R&D investment and activities
3.2.1.4 Growing pet ownership and spendings
3.2.2 Industry pitfall
3.2.2.1 Adverse effect of the treatment
3.2.2.2 Regulatory challenges
3.3.1 By animal type
3.3.2 By product type
3.3.3 By application
3.3.4 By end use
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Future market trend
3.6 Pet population, by country
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.1.1 Boehringer Ingelheim International GmbH
4.1.2 Dechra Pharmaceuticals PLC
4.1.3 VetStem, Inc.
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Veterinary Regenerative Medicine Market, By Animal Type
5.1 Cats 57
5.2 Dogs 57
5.3 Horses
5.4 Other animal types
Chapter 6 Veterinary Regenerative Medicine Market, By Product Type
6.1 Stem cell therapy
6.1.1 Autologous
6.1.2 Allogeneic
6.2 Biological therapy
6.2.1 Platelet rich plasma (PRP)
6.2.2 Growth factors
6.3 Tissue engineering
Chapter 7 Veterinary Regenerative Medicine Market, By Application
7.1 Orthopedics
7.2 Trauma/wound care
7.3 Other applications
Chapter 8 Veterinary Regenerative Medicine Market, By End Use
8.1 Veterinary hospitals
8.2 Veterinary clinics
8.3 Academic and research institutes
Chapter 9 Veterinary Regenerative Medicine Market, By Region
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and Africa
Chapter 10 Company Profiles
10.1 Animal Cell Therapies, Inc.
10.1.1 Global overview
10.1.2 Business overview
10.1.3 Financial data
10.1.4 Product landscape
10.1.5 SWOT analysis
10.2 Ardent
10.2.1 Global overview
10.2.2 Business overview
10.2.3 Financial data
10.2.4 Product landscape
10.2.5 Strategic outlook
10.2.6 SWOT analysis
10.3 Boehringer Ingelheim International GmbH
10.3.1 Global overview
10.3.2 Business overview
10.3.3 Financial data
10.3.3.1 Annual sales revenue, 2020 - 2023 (USD Million)
10.3.4 Product landscape
10.3.5 SWOT analysis
10.4 Cell Therapy Sciences Limited
10.4.1 Global overview
10.4.2 Business overview
10.4.3 Financial data
10.4.4 Product landscape
10.4.5 SWOT analysis
10.5 Dechra Pharmaceuticals PLC
10.5.1 Global overview
10.5.2 Business overview
10.5.3 Financial data
10.5.3.1 Annual sales revenue, 2020 - 2023 (USD Million)
10.5.4 Product landscape
10.5.5 Strategic outlook
10.5.6 SWOT analysis
10.6 Enso Discoveries
10.6.1 Global overview
10.6.2 Business overview
10.6.3 Financial data
10.6.4 Product landscape
10.6.5 Strategic outlook
10.6.6 SWOT analysis
10.7 EquiCord
10.7.1 Global overview
10.7.2 Business overview
10.7.3 Financial data
10.7.4 Product landscape
10.7.5 SWOT analysis
10.8 Lynch Biologics, LLC
10.8.1 Global overview
10.8.2 Business overview
10.8.3 Financial data
10.8.4 Product landscape
10.8.5 SWOT analysis
10.9 Magellan Stem Cells
10.9.1 Global overview
10.9.2 Business overview
10.9.3 Financial data
10.9.4 Product landscape
10.9.5 SWOT analysis
10.10 Medrego
10.10.1 Global overview
10.10.2 Business overview
10.10.3 Financial data
10.10.4 Product landscape
10.10.5 SWOT analysis
10.11 Regen Lab SA
10.11.1 Global overview
10.11.2 Business overview
10.11.3 Financial data
10.11.4 Product landscape
10.11.5 SWOT analysis
10.12 Vetherapy
10.12.1 Global overview
10.12.2 Business overview
10.12.3 Financial data
10.12.4 Product landscape
10.12.5 SWOT analysis
10.13 VetStem, Inc.
10.13.1 Global overview
10.13.2 Business overview
10.13.3 Financial data
10.13.4 Product landscape
10.13.5 Strategic outlook
10.13.6 SWOT analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us